← Back to Clinical Trials
Recruiting NCT07682753

NCT07682753 MH-POWER for College Students on the Spectrum

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07682753
Status Recruiting
Phase —
Sponsor University of Texas Rio Grande Valley
Condition Autistic College Students With Anxiety, Depression, Stress
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-07-01
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
The MH-POWER program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-07-01 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this project is to determine the feasibility and preliminary efficacy of a mental health skill-building and empowerment program (MH-POWER) for college students on the autism spectrum facing stress, anxiety, and depression. The program, grounded in cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and habit formation, will be implemented through weekly sessions and daily practice over 8 weeks. To evaluate the program's preliminary efficacy, we will measure mental health symptoms at baseline, mid-point, post-intervention, and one-month follow-up. Positive outcomes could lead to scalable interventions.

Eligibility Criteria

Inclusion Criteria * College students at The University of Texas Rio Grande Valley * age 18-30 years * self-reported autism diagnosis confirmed via Social Responsiveness Scale-2nd Edition, the gold standard to assess impairment in adults on the autism spectrum * elevated stress, anxiety (worry, feeling overwhelmed), or depression (feeling down), confirmed using highly reliable and validated screening tools; Patient Health Questionnaire-9, General Anxiety Disorder-7, Kessler Psychological Distress Scale-10 * not currently receiving intensive psychological treatment or psychiatric medication adjustments * must be able to speak and read English * willing to participate in an 8-week intervention study Exclusion criteria: \- None

Contact & Investigator

Central Contact

Wen-Pin Chang, PhD

✉ wenpin.chang@utrgv.edu

📞 9566656405

Frequently Asked Questions

Who can join the NCT07682753 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Autistic College Students With Anxiety, Depression, Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07682753 currently recruiting?

Yes, NCT07682753 is actively recruiting participants. Contact the research team at wenpin.chang@utrgv.edu for enrollment information.

Where is the NCT07682753 trial being conducted?

This trial is being conducted at Edinburg, United States.

Who is sponsoring the NCT07682753 clinical trial?

NCT07682753 is sponsored by University of Texas Rio Grande Valley. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology